9th Kidney Disease Clinical Trialists Workshop

April 4-5, 2025
Embassy of France, Washington DC

The Kidney Disease Clinical Trialists (KDCT) Workshop is a high level think-tank, with an exceptional expert faculty. It involves a limited number of attendees (up to 130) and includes distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R&D pharma, patient representatives and device companies, NIH, EMA, PMDA and FDA experts.

The KDCT Workshop aims to foster an international exchange of ideas where we will brainstorm on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for kidney disease.

Our objectives are to produce relevant data from controlled kidney disease clinical trials (beyond cardiovascular outcomes trials) that will contribute to better clinical care and to understand the problems associated with making decisions about what constitutes relevant information, how to improve kidney disease clinical trials, and, as is commonly the case, how to satisfy regulatory authorities and payers.

‍